Today: 4 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

EchoStar (SATS) Surges on SpaceX IPO Buzz and Morgan Stanley Upgrade: Latest News, Stock Forecasts and Key Risks (December 10, 2025)

EchoStar (SATS) Surges on SpaceX IPO Buzz and Morgan Stanley Upgrade: Latest News, Stock Forecasts and Key Risks (December 10, 2025)

EchoStar shares rose about 6% to $93.54 by mid-day Wednesday, up over 300% year-to-date, after Morgan Stanley upgraded the stock and raised its price target to $110. The move follows renewed speculation about a 2026 SpaceX IPO, with EchoStar holding $11.1 billion in SpaceX stock. EchoStar’s market cap stands near $27 billion. Analyst ratings range from “Hold” to “Moderate Buy.”
10 December 2025
····
Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands shares surged 12.4% to $8.09 on December 9, 2025, after weeks of steep declines and heavy trading volume. The rebound followed news of a Florida bill to allow home cannabis cultivation and renewed speculation over U.S. federal rescheduling. Tilray remains down 65% from its October high and recently completed a 1-for-10 reverse stock split.
10 December 2025
···
1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM shares jumped 32.8% to $4.94 on December 9, 2025, after naming Alexander Zelikovsky as Chief Information Officer to lead AI and digital commerce initiatives. Trading volume surged to 6.3 million shares. The stock remains down about 46% from its 52-week high, with its balance sheet and earnings still under pressure.
10 December 2025
···
Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (NYSE: XXI) debuted on the NYSE December 9, 2025, after merging with Cantor Equity Partners. Shares fell nearly 20% on the first day, closing at $11.42 despite the company holding over 43,500 Bitcoin. Early pre-market trading on December 10 showed a slight recovery toward $12.10. Jack Mallers leads the company, with Tether, Bitfinex, and SoftBank as major backers.
10 December 2025
··
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health raised its 2025–2026 profit outlook and launched an AI-driven engagement platform at its Investor Day in Hartford, sending shares up 2% to around $78 on December 10. The stock has surged nearly 80% year to date. CVS now expects at least $400 billion in 2025 revenue and adjusted EPS of $6.60–$6.70, above prior guidance. Management projects mid-teens adjusted EPS growth through 2028.
10 December 2025
··
Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver shares hit a 12-month high of $48.78 on December 10, 2025, after jumping 11% the previous day. The surge follows silver’s move above $60 per ounce and anticipation of a Federal Reserve rate cut. Trading volume topped 17 million shares, with the company’s market cap near $20.4 billion. Strong Q3 cash flow, higher production guidance, and recent acquisitions also supported the rally.
10 December 2025
··
BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies (BMNR) closed at $39.20 on December 9, 2025, up nearly 10%, with trading volume nearing $2 billion. The stock’s 52-week range spans $0.22 to $161, and its market cap fluctuates between $7–15 billion. BMNR now operates as an Ethereum-focused treasury and services platform, moving away from pure Bitcoin mining. Options activity shows heavy bullish speculation.
10 December 2025
··
Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) closed at $4.09 on December 9, down 53.5% from the prior session, after wild swings that saw the stock trade between $4.00 and $7.60 intraday. The company is advancing a Phase 3 trial in a rare inherited cancer syndrome and exploring new financing. Its float remains under 670,000 ADSs, fueling extreme volatility. Market cap stands near $5.5 million.
10 December 2025
··
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax shares surged as much as 20% on December 10, 2025, in Paris trading amid market rumors of a possible takeover bid by Eli Lilly. The stock hit a 52-week high near €126.60, with market value reaching about €9.7 billion. Abivax declined to comment, and no formal offer has been announced. U.S.-listed ADRs also jumped over 11% in pre-market trading.
10 December 2025
····
JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase shares fell nearly 5% on December 9 after executives projected 2026 expenses of about $105 billion, well above Wall Street estimates. The bank reaffirmed its $1.50 quarterly dividend. As of late morning December 10, shares traded near $300.50, recovering from the sharpest one-day drop in eight months. Analysts remain broadly positive on the stock’s long-term outlook.
10 December 2025
··
Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont shares rose 5.7% to $94.09 by mid-day on December 10, with trading volume near 8.7 million. The stock is up over 130% year-to-date, fueled by a surge in gold prices and company restructuring. Newmont sits just below its 52-week high of $98.58 reached in October. Analysts cite strong operational progress and increased mainstream investor interest.
10 December 2025
··
Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences shares surged over 70% in after-hours trading December 9, reaching around $10.29 after closing at $5.92, following news of a U.S. patent allowance for its EVM301 mental-health drug series. Pre-market quotes early December 10 ranged from $10.48 to $12.45 amid heavy volatility. The stock had fallen about 90% over the past year. The new patent covers both composition and method-of-use claims.
10 December 2025
Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle reports fiscal Q2 2026 earnings after market close, with consensus expecting revenue of $16.2 billion, up 15% year over year, and adjusted EPS of $1.64. Shares traded at $221.53 midday, up about a third in 2025. Options markets imply a 10% swing on the results. Wall Street is watching for signs that Oracle’s AI-driven cloud growth can withstand concerns over debt and customer concentration.
10 December 2025
····
Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Nvidia (NVDA) led U.S. trading volume on December 10, 2025, with about 145 million shares exchanged as the stock hovered near $185. Warner Bros. Discovery (WBD) surged after a $108 billion hostile bid from Paramount Skydance. Microcaps like Paranovus (PAVS) and Senti Biosciences (SNTI) posted sharp volume spikes. Wall Street traded cautiously ahead of the Federal Reserve’s final policy decision of the year.
10 December 2025
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Dyne Therapeutics shares fell 16.9% to $18.44 after announcing a $300 million stock offering. SLM Corp dropped 15%, Kontoor Brands slid 9.5%, and Waystar Holding lost 8.4%. Major indexes were little changed as investors awaited the Federal Reserve’s interest-rate decision. The U.S. 10-year Treasury yield hovered near 4.19%.
10 December 2025
···········
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

A SPAC III Acquisition (ASPC) surged over 100% pre-market Dec. 10, trading between $25 and $31 after sharp gains in after-hours. Enveric Biosciences (ENVB) and Biodexa Pharmaceuticals (BDRX) also posted triple- and double-digit percentage gains. Major U.S. index futures were little changed ahead of the Federal Reserve’s final 2025 rate decision. Speculative micro-caps and SPACs led early trading volatility.
10 December 2025
··········
Aimei Health Technology (AFJK) Stock Rockets Over 1,000% After Merger Extension: Latest News, Risks and Outlook

Aimei Health Technology (AFJK) Stock Rockets Over 1,000% After Merger Extension: Latest News, Risks and Outlook

Aimei Health Technology (NASDAQ: AFJK) surged 1,006% on December 9, closing at $88.50 after hitting an intraday high of $98.15 on heavy volume. The spike followed news of another extension in its planned merger with United Hydrogen Group. After-hours trading saw the stock drop to the mid-$40s before rebounding near the high-$80s on December 10. AFJK is a SPAC with about 6.1 million shares outstanding.
10 December 2025
··
GameStop (GME) Stock on December 10, 2025: Q3 Earnings Miss, Collectibles Boom and the Bitcoin Bet

GameStop (GME) Stock on December 10, 2025: Q3 Earnings Miss, Collectibles Boom and the Bitcoin Bet

GameStop shares traded near $23.11 late morning December 10, down about 1% after Q3 results showed net sales of $821 million, missing estimates and falling 4.6% year-over-year. Net income surged to $77.1 million from $17.4 million as cost cuts drove profitability. The stock initially dropped 5–6% after the report but recovered most losses. Year-to-date, shares remain down in the mid-20% range.
10 December 2025
···
Best Stocks to Buy Now (December 10, 2025): 8 U.S. Stocks Positioned for an AI‑Driven, Rate‑Cut Era

Best Stocks to Buy Now (December 10, 2025): 8 U.S. Stocks Positioned for an AI‑Driven, Rate‑Cut Era

The S&P 500 is up mid-teens percent for 2025, closing slightly lower as investors await the Federal Reserve’s December 9–10 policy decision, with futures suggesting a likely 25-basis-point rate cut. J.P. Morgan estimates AI-linked firms have driven about 75% of S&P 500 gains and 80% of earnings growth since late 2022.
10 December 2025
···
US Stock Market Today, December 10, 2025: Wall Street Pauses Near Record Highs Ahead of Fed’s Final Rate Cut of the Year

US Stock Market Today, December 10, 2025: Wall Street Pauses Near Record Highs Ahead of Fed’s Final Rate Cut of the Year

US stock index futures hovered near flat early Wednesday as investors awaited the Federal Reserve’s final interest-rate decision of 2025. On Tuesday, the S&P 500 slipped 0.1% to 6,840.51, the Dow fell 0.4%, and the Nasdaq edged up 0.1%. JPMorgan Chase dropped 4.7% after warning of higher expenses. Treasury yields climbed following strong job openings data.
10 December 2025
··
1 … 489 490 491 492 493 … 584
Go toTop